1.3(top 50%)
impact factor
17.5K(top 1%)
papers
111.4K(top 5%)
citations
74(top 10%)
h-index
1.4(top 50%)
impact factor
18.9K
all documents
116.2K
doc citations
99(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Choline PET or PET/CT and Biochemical Relapse of Prostate CancerClinical Nuclear Medicine2013255
2Brain PET in the Diagnosis of Alzheimer’s DiseaseClinical Nuclear Medicine2014239
3F-18 FDG Uptake in the Large ArteriesClinical Nuclear Medicine2001229
4Clinical Experience with Tc-99m MIBI Imaging in Patients with Malignant Tumors Preliminary Results and Comparison with TI-201Clinical Nuclear Medicine1992171
5Split Renal Function Testing Using Tc-99m DTPAClinical Nuclear Medicine1983169
668Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CTClinical Nuclear Medicine2016165
7Exclusion of Chronic Osteomyelitis With F-18 Fluorodeoxyglucose Positron Emission Tomographic ImagingClinical Nuclear Medicine2000161
8Radioligand Therapy With 177Lu-PSMA-617 as A Novel Therapeutic Option in Patients With Metastatic Castration Resistant Prostate CancerClinical Nuclear Medicine2016153
9SPECT Brain Perfusion Abnormalities in Mild or Moderate Traumatic Brain InjuryClinical Nuclear Medicine1998152
10Uptake and Kinetics of Tc-99m Hexakis 2-Methoxy Isobutyl Isonitrile in Benign and Malignant Lesions in the LungsClinical Nuclear Medicine1989151
11F-18 Fluorodeoxyglucose Chest Uptake in Lung Inflammation and InfectionClinical Nuclear Medicine2000149
12Evaluation of Chemotherapy Response in Primary Bone Tumors with F-18 FDG Positron Emission Tomography Compared with Histologically Assessed Tumor NecrosisClinical Nuclear Medicine2000148
13Image Analysis in Patients with Cancer Studied with a Combined PET and CT ScannerClinical Nuclear Medicine2000142
14Whole-Body FDG Positron Emission Tomographic Imaging for Staging Esophageal CancerClinical Nuclear Medicine2000137
15Diagnosing Spinal OsteomyelitisClinical Nuclear Medicine2000136
16SPECT Brain Imaging Abnormalities in Attention Deficit Hyperactivity DisorderClinical Nuclear Medicine1995134
17Low-Dose Oral Propranolol Could Reduce Brown Adipose Tissue F-18 FDG Uptake in Patients Undergoing PET ScansClinical Nuclear Medicine2007129
18Prospective Evaluation of 18F-NaF and 18F-FDG PET/CT in Detection of Occult Metastatic Disease in Biochemical Recurrence of Prostate CancerClinical Nuclear Medicine2012125
19F-18 FDG Whole-Body PET for the Assessment of Disease Activity in Patients With Rheumatoid ArthritisClinical Nuclear Medicine2006122
20The Role of Fluorine-18 Deoxyglucose Positron Emission Tomography in the Management of Patients With Metastatic Melanoma: Impact on Surgical Decision MakingClinical Nuclear Medicine2003119
21FDG Positron Emission Tomography in the Surveillance of Hepatic Tumors Treated with Radiofrequency AblationClinical Nuclear Medicine2003119
22F-18 FDG PET/CT in the Diagnosis of Fever of Unknown OriginClinical Nuclear Medicine2009119
2318F-Fluciclovine PET/CT for the Detection of Prostate Cancer RelapseClinical Nuclear Medicine2015118
24Glucose Transporter 1 Expression, Tumor Proliferation, and Iodine/Glucose Uptake in Thyroid Cancer With Emphasis on Poorly Differentiated Thyroid CarcinomaClinical Nuclear Medicine2012115
25Scintigraphic Evaluation of Salivary Gland Dysfunction in Patients with Thyroid Cancer After Radioiodine TreatmentClinical Nuclear Medicine2002114
26Differentiating Benign from Malignant Lung Lesions Using “Quantitative” Parameters of FDG PET ImagesClinical Nuclear Medicine1996114
27F-18-FDG Uptake in TuberculosisClinical Nuclear Medicine1998114
28Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine (F-18 FET) PET for Glioma GradingClinical Nuclear Medicine2011113
29Low Iodine Diet in I-131 Ablation of Thyroid RemnantsClinical Nuclear Medicine1983110
30Superiority of Iodine-123 Compared with Iodine-131 Scanning for Thyroid Remnants in Patients with Differentiated Thyroid CancerClinical Nuclear Medicine2001109
31Dual-Time Point FDG PET Imaging in the Evaluation of Pulmonary Nodules With Minimally Increased Metabolic ActivityClinical Nuclear Medicine2007109
32Whole-Body Scintigraphy With Radioiodine-131 A Comprehensive List of False-Positives With Some ExamplesClinical Nuclear Medicine1995108
33FDG PET or PET/CT for Detecting Intramedullary and Extramedullary Lesions in Multiple MyelomaClinical Nuclear Medicine2012107
34Comparative Evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for Metabolic Imaging of Low Grade GliomasClinical Nuclear Medicine2009104
35Diagnostic Value of 68Ga PSMA-11 PET/CT Imaging of Brain Tumors—Preliminary AnalysisClinical Nuclear Medicine2017102
36F-18 FDG Uptake in Breast Infection and InflammationClinical Nuclear Medicine2000102
37A Machine-Learning Approach Using PET-Based Radiomics to Predict the Histological Subtypes of Lung CancerClinical Nuclear Medicine2019101
38FDG-PET Imaging in Primary Bilateral Adrenal Lymphoma: A Case Report and Review of the LiteratureClinical Nuclear Medicine200596
39Comparative Effectiveness of Ultrasonography, 99mTc-Sestamibi, and 18F-Fluorocholine PET/CT in Detecting Parathyroid Adenomas in Patients With Primary HyperparathyroidismClinical Nuclear Medicine201796
40Hematopoietic Cytokine-Mediated FDG Uptake Simulates the Appearance of Diffuse Metastatic Disease on Whole-Body PET ImagingClinical Nuclear Medicine199895
41Elimination of Artifactual Accumulation of FDG in PET Imaging of Colorectal CancerClinical Nuclear Medicine199894
42Diagnostic Value of FDG PET and Salivary Gland Scintigraphy for Parotid TumorsClinical Nuclear Medicine200593
43Meta-analysis: Comparison of F-18 Fluorodeoxyglucose-Positron Emission Tomography and Bone Scintigraphy in the Detection of Bone Metastases in Patients With Breast CancerClinical Nuclear Medicine200893
44Clinical Applications of Hybrid PET/MRI in NeuroimagingClinical Nuclear Medicine201392
45Accuracy of 18F-FDG PET/CT for Diagnosing Inguinal Lymph Node Involvement in Penile Squamous Cell CarcinomaClinical Nuclear Medicine201291
46The Scope of False-Positive lodine-131 Images for Thyroid CarcinomaClinical Nuclear Medicine198989
47A Comparative Study of Fused FDG PET/MRI, PET/CT, MRI, and CT Imaging for Assessing Surrounding Tissue Invasion of Advanced Buccal Squamous Cell CarcinomaClinical Nuclear Medicine201189
48Comparison of 18F-FDG and 68Ga DOTATATE PET/CT in Localization of Tumor Causing Oncogenic OsteomalaciaClinical Nuclear Medicine201588
49Therapeutic Responses and Survival Effects of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castrate-Resistant Prostate CancerClinical Nuclear Medicine201888
50Radionuclide Lymphangioscintigraphy in the Evaluation of Peripheral LymphedemaClinical Nuclear Medicine200087